STOCK TITAN
  1. Home
  2. Sec-filings
  3. INGN
  4. [Form 4] Inogen Inc Insider Trading Activity

Inogen CEO buys 1,500 shares at $5.33

Inogen’s CEO increased his direct holdings via a 1,500-share ESPP purchase under a Rule 10b5-1 plan.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Inogen Inc (INGN) reports that CEO, President, and director Kevin Raymond Merrill Smith acquired 1,500 shares of common stock on September 1, 2026 through the company’s 2014 Employee Stock Purchase Plan at $5.33 per share. The filing shows he now directly owns 134,962 shares, with the transaction made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Smith Kevin Raymond Merrill
Role CEO and President
Type Security Shares Price Value
Grant/Award Common Stock F1 1,500 $5.33 $8K
Holdings After Transaction: Common Stock — 134,962 shares (Direct)
Footnotes (1)
  1. F1. Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
Shares acquired 1,500 shares Common stock acquired on September 1, 2026 via 2014 Employee Stock Purchase Plan
Purchase price per share $5.33 per share Price for ESPP acquisition of 1,500 Inogen Inc common shares
Holdings after transaction 134,962 shares CEO’s direct ownership of Inogen Inc common stock following the ESPP acquisition
Employee Stock Purchase Plan financial
"Shares acquired through the Company's 2014 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 10b5-1 trading plan regulatory
"The filing indicates the transaction was under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
grant, award, or other acquisition financial
"The filing classifies the event as a grant, award, or other acquisition"

FAQ

What insider transaction did INGN report for CEO Kevin Raymond Merrill Smith?
Inogen Inc reported that CEO Kevin Raymond Merrill Smith acquired 1,500 shares of common stock on September 1, 2026 through the 2014 Employee Stock Purchase Plan at $5.33 per share, increasing his direct ownership to 134,962 shares.

Was the recent INGN insider transaction made under a Rule 10b5-1 plan?
Yes. The Form 4 indicates the transaction was made under a Rule 10b5-1 trading plan, meaning the purchase was carried out according to a pre-established plan rather than being timed discretionarily.

How many INGN shares does the CEO hold after the reported transaction?
After acquiring 1,500 shares through the 2014 Employee Stock Purchase Plan, CEO Kevin Raymond Merrill Smith directly owns 134,962 shares of Inogen Inc common stock according to the Form 4.

What price did the INGN CEO pay per share in the ESPP acquisition?
The CEO acquired the 1,500 shares of Inogen Inc common stock at a price of $5.33 per share through the company’s 2014 Employee Stock Purchase Plan on September 1, 2026.

What type of transaction was reported for INGN’s CEO on the Form 4?
The filing classifies the event as a grant, award, or other acquisition of common stock, specifically shares acquired through the Company’s 2014 Employee Stock Purchase Plan, rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smith Kevin Raymond Merrill
(Last)(First)(Middle)
C/O INOGEN, INC.
500 CUMMINGS CENTER, SUITE 2800
(Street)
BEVERLY MASSACHUSETTS 01915
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026A1,500(1)A$5.33134,962D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
/s/ Mary Wright, as Attorney-in-Fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR